Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity
This cohort study evaluates early treatment trends of oral semaglutide among adults eligible for obesity management medications following its approval for obesity.
Authors
- David A. Asch (ORCID: https://orcid.org/0000-0002-7970-286X)
- Xinyao Jian (ORCID: https://orcid.org/0000-0001-6322-9273)
- Huilin Tang
- Yuqing Lei
- Yong Chen
Institutions
- Penn Presbyterian Medical Center (US)
- University of Pennsylvania Health System (US)
- Leonard Davis Institute of Health Economics (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-10-07
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.37779
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00